Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PIK3CB | P42338 | 15/20 | 0.47 |
| ▸ | PIK3CG | P48736 | 15/20 | 0.47 |
| ▸ | PIK3CA | P42336 | 15/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 14/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28299566 | 0.99 | PIK3CB (0.47) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL28028870 | 0.89 | PIK3CB (0.47) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL28029240 | 0.88 | PIK3CB (0.48) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL28299572 | 0.85 | PIK3CD (0.47) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL28298220 | 0.84 | PIK3CD (0.52) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL28298250 | 0.83 | PIK3CA (0.66) | PIK3CBPIK3CGPIK3CAPIK3CDADORA1 | |
| SCHEMBL28298209 | 0.83 | PIK3CD (0.48) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL300811 | 0.83 | PIK3CB (0.69) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL28299551 | 0.83 | PIK3CD (0.47) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 | |
| SCHEMBL28299846 | 0.83 | PIK3CD (0.49) | PIK3CBPIK3CGPIK3CAPIK3CDCSNK2A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109846884-A | With TOR kinase inhibitor for treating cancer | 西格诺药品有限公司 | 2019-06-07 | — | — | CN | disclosed |